Simple Therapies Boost Heart Attack Survival
Mukherjee believes the Swedish research could yield similar results in the U.S.
According to research recently published in the Journal of the American Medical Association and an accompanying commentary by Debabrata Mukherjee, M.D., chief of cardiovascular medicine at the Paul L. Foster School of Medicine, the increased use of evidence-based treatments for heart attacks like rapid angioplasty has led to a decrease in deaths from heart attacks.
Cardiovascular disease remains the most common cause of morbidity and mortality in the U.S.
In the study, Thomas Jernberg of the Karolinska Institute in Stockholm and his colleagues used data from a Swedish registry on more than 61,000 patients who experienced a deadly heart attack known as STEMI between 1996 and 2007.
“The combined use of simple therapies such as aspirin and cholesterol-lowering medications and balloon stents were associated with a significant reduction in mortality,” Mukherjee said. “We would expect to have similar findings in the United States.”
Read the full story from Reuters >>
Related
PAP Smears: What, Why and When
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.